- Home
- FFIV vs SRPT Comparison
FFIV vs SRPT Comparison
Compare FFIV & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIV
- SRPT
- Stock Information
- Founded
- FFIV 1996
- SRPT 1980
- Country
- FFIV United States
- SRPT United States
- Employees
- FFIV N/A
- SRPT N/A
- Industry
- FFIV Computer Communications Equipment
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- FFIV Telecommunications
- SRPT Health Care
- Exchange
- FFIV Nasdaq
- SRPT Nasdaq
- Market Cap
- FFIV 15.2B
- SRPT 12.2B
- IPO Year
- FFIV 1999
- SRPT 1997
- Fundamental
- Price
- FFIV $252.00
- SRPT $120.25
- Analyst Decision
- FFIV Hold
- SRPT Buy
- Analyst Count
- FFIV 9
- SRPT 21
- Target Price
- FFIV $237.11
- SRPT $179.38
- AVG Volume (30 Days)
- FFIV 504.7K
- SRPT 1.0M
- Earning Date
- FFIV 01-27-2025
- SRPT 11-06-2024
- Dividend Yield
- FFIV N/A
- SRPT N/A
- EPS Growth
- FFIV 45.80
- SRPT N/A
- EPS
- FFIV 9.55
- SRPT 1.22
- Revenue
- FFIV $2,816,120,000.00
- SRPT $1,640,348,000.00
- Revenue This Year
- FFIV $6.78
- SRPT $50.40
- Revenue Next Year
- FFIV $3.79
- SRPT $71.44
- P/E Ratio
- FFIV $26.39
- SRPT $98.58
- Revenue Growth
- FFIV 0.10
- SRPT 48.45
- 52 Week Low
- FFIV $159.01
- SRPT $89.92
- 52 Week High
- FFIV $264.50
- SRPT $173.25
- Technical
- Relative Strength Index (RSI)
- FFIV 52.23
- SRPT 44.95
- Support Level
- FFIV $254.27
- SRPT $122.12
- Resistance Level
- FFIV $264.50
- SRPT $128.73
- Average True Range (ATR)
- FFIV 4.32
- SRPT 4.13
- MACD
- FFIV -0.78
- SRPT -0.38
- Stochastic Oscillator
- FFIV 16.50
- SRPT 2.16
About FFIV F5 Inc.
F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.